These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30968254)

  • 1. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.
    Nishimura J; Tanaka H; Yamakoshi Y; Hiramatsu S; Tamura T; Toyokawa T; Muguruma K; Maeda K; Hirakawa K; Ohira M
    Esophagus; 2019 Oct; 16(4):333-344. PubMed ID: 30968254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma.
    Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D
    Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.
    Truxova I; Kasikova L; Hensler M; Skapa P; Laco J; Pecen L; Belicova L; Praznovec I; Halaska MJ; Brtnicky T; Salkova E; Rob L; Kodet R; Goc J; Sautes-Fridman C; Fridman WH; Ryska A; Galluzzi L; Spisek R; Fucikova J
    J Immunother Cancer; 2018 Dec; 6(1):139. PubMed ID: 30526667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma.
    Wang J; Jia Y; Wang N; Zhang X; Tan B; Zhang G; Cheng Y
    J Transl Med; 2014 Jan; 12():7. PubMed ID: 24397835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD103
    Han L; Gao QL; Zhou XM; Shi C; Chen GY; Song YP; Yao YJ; Zhao YM; Wen XY; Liu SL; Qi YM; Gao YF
    Cancer Immunol Immunother; 2020 Aug; 69(8):1493-1504. PubMed ID: 32285170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma.
    Lv L; Pan K; Li XD; She KL; Zhao JJ; Wang W; Chen JG; Chen YB; Yun JP; Xia JC
    PLoS One; 2011 Mar; 6(3):e18219. PubMed ID: 21483813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
    Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
    Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma.
    Hu J; Toyozumi T; Murakami K; Endo S; Matsumoto Y; Otsuka R; Shiraishi T; Iida S; Morishita H; Makiyama T; Nishioka Y; Uesato M; Hayano K; Nakano A; Matsubara H
    Cancer Med; 2024 Sep; 13(17):e70179. PubMed ID: 39264227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
    Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.
    Zhang G; Liu WL; Zhang L; Wang JY; Kuang MH; Liu P; Lin YH; Dai SQ; Du J
    Clin Dev Immunol; 2011; 2011():384726. PubMed ID: 22013481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased HIF-1alpha expression in tumor cells and lymphocytes of tumor microenvironments predicts unfavorable survival in esophageal squamous cell carcinoma patients.
    Zhang L; Ye SB; Li ZL; Ma G; Chen SP; He J; Liu WL; Xie D; Zeng YX; Li J
    Int J Clin Exp Pathol; 2014; 7(7):3887-97. PubMed ID: 25120765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer.
    Zhu Y; Li M; Mu D; Kong L; Zhang J; Zhao F; Li Z; Liu X; Bo C; Yu J
    Oncotarget; 2016 Nov; 7(44):71455-71465. PubMed ID: 27683115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
    Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
    Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between expression of PD-L1 and PD-L2 on esophageal squamous cell carcinoma and the antitumor effects of CD8⁺ T cells.
    Leng C; Li Y; Qin J; Ma J; Liu X; Cui Y; Sun H; Wang Z; Hua X; Yu Y; Li H; Zhang J; Zheng Y; Wang W; Zhu J; Wang Q
    Oncol Rep; 2016 Feb; 35(2):699-708. PubMed ID: 26718132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct compartmental distribution of mature and immature dendritic cells in esophageal squamous cell carcinoma.
    Liu J; Lu G; Li Z; Tang F; Liu Y; Cui G
    Pathol Res Pract; 2010 Sep; 206(9):602-6. PubMed ID: 20547010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased intraepithelial CD3+ T-lymphocytes and high PD-L1 expression on tumor cells are associated with a favorable prognosis in esophageal squamous cell carcinoma and allow prognostic immunogenic subgrouping.
    Jesinghaus M; Steiger K; Slotta-Huspenina J; Drecoll E; Pfarr N; Meyer P; Konukiewitz B; Bettstetter M; Wieczorek K; Ott K; Feith M; Langer R; Weichert W; Specht K; Boxberg M
    Oncotarget; 2017 Jul; 8(29):46756-46768. PubMed ID: 28657901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significances of natural killer cells and dendritic cells infiltrations in esophageal squamous cell carcinoma].
    Cao FM; Zhang XH; Yan X; Wang JL; Wang XL; Zhang ZG; Shen HT; Wang FR
    Ai Zheng; 2005 Feb; 24(2):232-6. PubMed ID: 15694042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.
    Jiang D; Liu Y; Wang H; Wang H; Song Q; Sujie A; Huang J; Xu Y; Zeng H; Tan L; Hou Y; Xu C
    Sci Rep; 2017 Mar; 7():44823. PubMed ID: 28322245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma.
    Hatogai K; Fujii S; Kitano S; Kojima T; Daiko H; Yoshino T; Ohtsu A; Takiguchi Y; Doi T; Ochiai A
    Br J Cancer; 2020 Feb; 122(3):413-420. PubMed ID: 31761900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma.
    Reichert TE; Scheuer C; Day R; Wagner W; Whiteside TL
    Cancer; 2001 Jun; 91(11):2136-47. PubMed ID: 11391595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.